Paul M Haller - JoVE Visualize

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

European Journal of Preventive Cardiology|April 20, 2023

Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals with diabetes mellitusPaul M Haller, Alina Goßling, Christina Magnussen, et al.

Atherosclerosis|May 1, 2026

Enhanced risk for recurrent adverse cardiovascular events in homozygous carriers of the T-allele of CD40 SNP rs1883832Mark Colin Gissler, Johannes Neumann, Linlin Guo, et al.

Circulation|August 30, 2025

Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart FailureDavid D Berg, Siddharth M Patel, Paul M Haller, et al.

Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

European Journal of Preventive Cardiology|April 20, 2023

Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals with diabetes mellitusPaul M Haller, Alina Goßling, Christina Magnussen, et al.

Atherosclerosis|May 1, 2026

Enhanced risk for recurrent adverse cardiovascular events in homozygous carriers of the T-allele of CD40 SNP rs1883832Mark Colin Gissler, Johannes Neumann, Linlin Guo, et al.

Circulation|August 30, 2025

Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart FailureDavid D Berg, Siddharth M Patel, Paul M Haller, et al.

Pageof 5